{"id":"induction-cycles-a4-5","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Cardiotoxicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a multi-agent induction chemotherapy protocol used in pediatric acute leukemia treatment. The regimen combines multiple chemotherapeutic drugs administered in a specific sequence to achieve maximal cytotoxic effect against leukemic blasts while attempting to minimize cumulative toxicity. The exact drug composition and dosing schedule follows a standardized protocol developed by Nationwide Children's Hospital for initial disease control.","oneSentence":"Induction Cycles A4-5 is a chemotherapy regimen designed to induce remission in pediatric leukemia patients through sequential administration of multiple cytotoxic agents.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:48:26.048Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute lymphoblastic leukemia (ALL) induction therapy in pediatric patients"},{"name":"Acute myeloid leukemia (AML) induction therapy in pediatric patients"}]},"trialDetails":[{"nctId":"NCT07291102","phase":"PHASE3","title":"Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma","status":"NOT_YET_RECRUITING","sponsor":"Nationwide Children's Hospital","startDate":"2026-07-01","conditions":"Medulloblastoma","enrollment":96},{"nctId":"NCT05960604","phase":"","title":"Pressure Recording Analytical Method Parameters and Their Relationship With Hypotension in Hypertensive Patients","status":"RECRUITING","sponsor":"Recep Tayyip Erdogan University","startDate":"2024-02-19","conditions":"Cardiovascular Diseases, Surgery, Hypotension","enrollment":660},{"nctId":"NCT02180984","phase":"NA","title":"The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2015-11","conditions":"Binge Eating, Obesity","enrollment":95},{"nctId":"NCT02871284","phase":"NA","title":"Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training","status":"COMPLETED","sponsor":"German Cancer Research Center","startDate":"2016-04","conditions":"Exercise, Chemotherapy-induced Polyneuropathy","enrollment":170}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Induction Cycles A4-5","genericName":"Induction Cycles A4-5","companyName":"Nationwide Children's Hospital","companyId":"nationwide-children-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Induction Cycles A4-5 is a chemotherapy regimen designed to induce remission in pediatric leukemia patients through sequential administration of multiple cytotoxic agents. Used for Acute lymphoblastic leukemia (ALL) induction therapy in pediatric patients, Acute myeloid leukemia (AML) induction therapy in pediatric patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}